PEG-interferon is used in combination with ribavirin to treat hepatitis C. Since the emergence of a new group of drugs known as DAAs (Direct-Acting Antivirals) the use of interferon has decreased.
PEG-interferon and ribavirin and the benefit of DNA analysis
The efficacy of combination therapy with PEG-interferon and ribavirin varies from one individual to another. This means that the efficacy and side effects of PEG-interferon and ribavirin can be predicted to some extent on the basis of your genes. Preventive DNA analysis can therefore be an important tool in optimising your medication.
Also known as